Veloxis Pharmaceuticals
Jason Grillot is an experienced executive in the pharmaceutical and healthcare industries, currently serving as the Executive Director of Global Strategy and Planning at Veloxis Pharmaceuticals, Inc. since March 2024. Prior to this role, Jason held a consulting position at GC Consulting and served as VP of Sales and Marketing for Acute Care at Heron Therapeutics, Inc. from April 2023 to October 2023. Jason's extensive background includes various leadership roles at Chiesi USA, Inc. spanning over a decade, where responsibilities encompassed business excellence, national sales, and account management. Earlier in Jason's career, key roles were held at Dey, L.P. and Innovex, contributing to sales management and mental health sales. Jason earned a Bachelor of Science in Clinical Nutrition from the University of Kentucky.
This person is not in any offices
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®.